Moving up against the market
Eti Amegor of Axius Partners (and (VIEW LINK) joins us to talk about how some sectors are rallying while the market itself stays under pressure.
0:52 - Opportunities during the coronavirus
1:55 - Current investor trends regarding liquidity
3:30 - The new private equity fund being launched by Eti's firm
6:30 - Why the coronavirus is the best environment for active investment managers
8:00 - Life Sciences stocks and the coronavirus
9:30 - Mike talks through Moderna, which focuses on drug discovery and development based on messenger RNA
10:50 - Eti and Mike talk Afterpay (again)
14:00 - The endgame... Afterpay vs Paypal
16:55 - Why Frazis Capital does not buy Big Tech
17:10 - Mike introduces MercadoLibre, a new portfolio holding
18:30 - Mike introduces Sea, another new portfolio holding
20:00 - Shopify has performed superbly... is it still worth the valuation?
23:55 - Investment thematics within Frazis Capital Partners
25:20 - Mike discusses three digital health investment opportunities
28:30 - Frazis Capital's recent approach to a more diversified portfolio construction
34:30 - The fund's approach to adding new positions to the portfolio
37:10 - The underperformance of 70+ stock portfolios
41:00 - The issues that fund managers face when running highly consolidated portfolios
43:50 - Why Eti believes that Frazis Capital is in the 'sweet spot'
52:00 - Frazis Capital's up and coming webinar
MORE ON Equities
Michael manages a global equity investment fund focused on technology and the life sciences. Michael completed undergraduate and graduate chemistry degrees at Magdalen College, Oxford University, and studied finance at the London School of Economics